Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antipyretic Therapy's future.

P A Mackowiak1

  • 1Medical Care Clinical Center, VA Maryland Health Care System and the Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Philip.Mackowiak@med.va.gov

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between age and fever magnitude.

The American journal of the medical sciences·2001
Same author

Noble heart.

The American journal of medicine·2001
Same author

Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections.

Pharmacotherapy·2000
Same author

Brief history of antipyretic therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Physiological rationale for suppression of fever.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same author

Diagnostic implications and clinical consequences of antipyretic therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2000
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Clinicians are exploring novel antipyretic agents and strategies to improve fever management. Future efforts will focus on optimizing benefits, minimizing side effects, and clarifying appropriate uses of fever-reducing therapies.

Area of Science:

  • Pharmacology and Therapeutics
  • Clinical Medicine

Background:

  • Fever management remains a key clinical challenge.
  • Continuous innovation is needed for effective antipyretic therapies.

Purpose of the Study:

  • To explore advancements in fever suppression.
  • To identify new antipyretic agents and applications.
  • To optimize existing fever-reducing treatments.

Main Methods:

  • Literature review of current and emerging antipyretic strategies.
  • Analysis of potential new drug development pathways.
  • Evaluation of therapeutic benefit-risk profiles.

Main Results:

  • Anticipation of novel antipyretic agents.

Related Experiment Videos

  • Identification of new uses for existing medications.
  • Development of strategies to enhance efficacy and safety.

    • Conclusions:

    • Ongoing research aims to refine fever suppression.
    • Focus on maximizing therapeutic benefits while minimizing adverse events.
    • Emphasis on establishing clear guidelines for antipyretic use.